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SHORT COMMUNICATION
12-0-Tetradecanoylphorbol 13-acetate induced differentiation in human
lung squamous carcinoma cells
G.J. Rabiasz, S.P. Langdon, L. Anderson, A.A. Ritchie, W.R. Miller & J.F. Smyth
ICRF Medical Oncology Unit, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU, UK.
Summary Three human lung squamous carcinoma cell lines (NX002, CX140 and CX143) demonstrate
features of squamous differentiation including involucrin synthesis and competence to form comified
envelopes. 12-O-Tetradecanoylphorbol 13-acetate inhibits growth of these cell lines and this growth inhibition
is associated with enhanced differentiation.
Squamous cell carcinoma is the most common subtype of
non-small cell lung cancer and represents 40% of all lung
cancer cases (Minna et al., 1989). The factors that control
proliferation and differentiation in this disease are poorly
understood and an improved knowledge of these might aid
the development of therapeutic strategies such as the use of
differentiation induction in this tumour type (Bloch, 1984;
Sartorelli, 1985). Lung squamous carcinoma cells undergoing
terminal differentiation demonstrate a number of features
including expression of involucrin (a protein precursor found
beneath the plasma membrane prior to terminal different-
iation) and the ability to form cornified envelopes (Miyazaki
et al., 1982; Banks-Schlegel et al., 1985; Levitt et al., 1990;
Said et al., 1983; Salge et al., 1990). Cytokeratins 4, 7,
8, 10, 13 and 19 have been detected in this subtype of lung
cancer and cytokeratins 10 and 13 have been proposed to be
characteristic of squamous differentiation (Broers et al.,
1988).
In the present study, we describe differentiation features
within three new cell lines and show how they relate to the
xenografts from which they were derived. The effect of the
differentiation inducer 12-O-tetradecanoylphorbol 13-acetate
(TPA) on the growth and differentiation of these cell lines
was then investigated.
Materials and methods
The three xenografts from which the cell lines were derived
were obtained from untreated patients in 1983 and brief
details of these xenografts have previously been reported
(Fergusson et al., 1986). The pathology of both the NX002
and CX140 xenografts is consistent with that of poorly
differentiated lung squamous carcinoma and has remained
constant over the last 7 years. The CX143 xenograft was
obtained from a patient with adenosquamous carcinoma and
although both adeno and squamous components could be
observed in early passages of the xenograft, the pathology of
later passages was consistent with a poorly differentiated
squamous carcinoma.
Cell lines were derived from all three xenografts between
their 20th and 27th passages and grown in RPMI 1640 media
supplemented with 5% foetal calf serum (FCS), streptomycin
(100 igml-'), penicillin (1OOIUml-') and glutamine (2g.M)
and kept at 37°C in 5% CO2 and 90% humidity. For these
experiments, cell lines were in their 6th-20th passage.
For experiments wherein the effects of TPA on growth
were examined, cells in exponential phase of growth were
trypsinised and plated into 24 well trays at a density of
5 x I04 cells/well. Twenty-four hours later, TPA at concen-
trations ranging from 10`0 to 10-6 M was added to quadrup-
licate wells. After 4 days, cells were trypsinised and counted
using a ZF coulter counter.
For detection of antigens, cells were stained by an indirect
immunoperoxidase method using avidin-biotinylated
horseradish peroxidase complex (Hsu et al., 1981). Mouse
monoclonal antibodies were used except for the detection of
involucrin. EGFR1 was a gift from Dr W. Gullick, ICRF,
London and was used at a dilution of 1:10 of the super-
natant. AUA1, HMFG1 and CAM 5.2 were also from
ICRF, London and were used as supernatants. Anti-vimentin
and anti-desmoplakin I/II were obtained from Beorhinger
(Mannheim) and used at a dilution of 5 jig ml-'. MoAbs to
cytokeratins 4 (clone 6B10), 10 (clone RKSE 60) and 13
(clones 1C7 and 2D7) were obtained from ICN Immuno-
Biologicals, USA and used at a dilution of 1:5 of the super-
natant. Rabbit antiserum to involucrin was a gift from Dr F.
Watt, ICRF, London and was used at a dilution of 1:500.
The competence of cells to form cornified envelopes was
determined essentially according to the method described by
Rice and Green (1979). Semi-confluent cultures were treated
with or without TPA in RPMI 1640 medium containing 5%
serum for 4 days. Cells were trypsinised, washed twice with
RPMI 1640 medium and either placed onto multispot slides
to stain for involucrin expression or resuspended at a density
of 106 cell ml-' in the same medium with or without 0.8 M
NaCI for 4 h at 37°C to assay envelope competence. Cell
suspensions in phosphate buffered saline containing 2%
sodium dodecyl sulphate and 20 mM P-mercaptoethanol were
boiled for 2 min. Cornified envelopes surviving this treatment
were observed in a haemocytometer chamber using a micro-
scope.
Results
The three cell lines, NXO02, CX140 and CX143, all grow on
plastic as monolayers with an epitheloid morphology, but
show some degree of stratification (Figure 1). The expression
of a number of antigens known to be present in primary lung
squamous carcinoma was examined using monoclonal
antibodies. The percentage of cells staining positively for
each of these antigens is shown in Table I. Epithelial markers
including the EGF receptor, human milk fat globule antigen,
the protein identified by AUA1 and desmoplakin I/II were
present in the majority of cells in all three cell lines. Of the
cytokeratins claimed to be specifically associated with lung
squamous carcinoma, cytokeratin 13 was found in approx-
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Figure 1 Plates of the cell lines and xenografts. a, NX002 cell line; b, CX140 cell line; c, CX143 cell line; d, NX002 xenograft; e,
CX140 xenograft; f, CX143 xenograft. The cell lines were photographed at a magnification of x 125 and the xenograft sections at
x 312.5.
imately 1% of cells in all lines while cytokeratins 4 and 10
could not be detected. The antibody CAM 5.2 which reacts
with cytokeratins 7, 8 and 18 reacted with the majority of
cells as did an antibody against another intermediate
filament, vimentin.
Within all three xenografts from which the cell lines were
derived, areas of involucrin expression were observed in
frozen sections and correlated with areas of pathological
differentiation and keratinisation. The percentage of cells
positive for involucrin and with the ability to form cornified
envelopes was studied in the cell lines. A low percentage of
cells (<1%) were positive for both these markers (Figure 2).
Treatment with a high concentration of NaCl was necessary
to induce formation of cornified envelopes (by increasing the
intracellular Ca2+ concentration [Rice & Green, 1979]) as
<1 pre-existing envelope/1000 cells could be identified
within these cultures. Involucrin expression had been
examined in NX002 cells at Passage 4 and found to be
present in approximately 14% of cells but with time in
culture this percentage decreased to <1%.
The expression of these markers in the cell lines was
examined after 4 days exposure to the differentiation inducer
TPA. A concentration of 10- M was selected as this pro-
duced optimal inhibition of growth within the cell lines
(Figure 3). Concentrations of TPA greater than 10- M
resulted in decreased inhibition. All three cell lines showed
marked increases in the percentage of cells positive for
involucrin and competent to form cornified envelopes after
d
f
TPA INDUCED DIFFERENTIATION IN LUNG CARCINOMA 441
Table I Antigen expression of the cell lines
% Cells + ve
Moab Antigen detected NX002 CXJ40 CX143
EGFR1 EGF receptor 69± 6a 71 ± 9 92± 1
HMFG1 Human milk fat globule membrane NEb NE 86± 2
AUA1 35 kD epithelial protein 43 ± 16 73 ± 6 62 ± 14
CAM 5.2 Cytokeratins 8, 18, 19 69 +10 83 +5 88+ 3
6B10 Cytokeratin 4 0 0 0
RKSE 60 Cytokeratin 10 0 0 0
1C7 Cytokeratin 13 <1 <1 <1
2D7 Cytokeratin 13 <1 <1 <1
DP1.2-2.15 Desmoplakin I and II 66 ± 4 77 ± 8 88 ± 2
V9 Vimentin 59 3 86 2 72 3
aMean ± standard error of at least 4 independent measurements shown. bNon.evaluable.
The level ofstaining with this antibody in these cell lines was too weak to allow an accurate
assessment of the percentage of positive cells.
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Figure 2 Differentiation markers within the cell lines and modulation by TPA. The mean percentages of cells ( ± standard error)
positive for involucrin or competent to form cornified envelopes in the cell lines are shown with or without exposure to 10-8M TPA
for 4 days. Mean values were obtained from six independent experiments. The methods used to identify involucrin expression and
to measure competence to form cornified envelopes are described in Materials and methods.
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Figure 3 The effect of TPA on growth of the cell lines. Cells growing in the logarithmic phase of growth were exposed to TPA for
4 days at the concentration indicated. Mean cell numbers ( ± standard error) are shown as a percentage of the control count. The
mean value was obtained from three independent experiments.
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exposure to 10-8 M TPA consistent with enhanced
differentiation (Figure 2). The effect of different concentra-
tions of TPA on these two markers was examined in the
NX002 cell line and optimal induction was produced at
concentrations of 1O- -1O-7M (Figure 4).
Discussion
The antigen expression of these cell lines is typical of
squamous epithelium confirming the histology of the cell
lines. Thus a marker such as the EGF receptor which can be
detected in 75% of primary lung squamous carcinomas by
the EGFR1 antibody (Cerny et al., 1986; Berger et al., 1987)
was present in the majority of cells in these lines. In a study
by Moss et al. (1986), the epithelial markers detected by
HMFG1, AUA1 and CAM 5.2 were reported to be on all of
the primary lung squamous carcinomas studied (17/17). All
these markers were found in the cell lines. Of the
cytokeratins reported to be characteristic of lung squamous
carcinoma (Broers et al., 1988), cytokeratin 13 was observed
in occasional cells in these lines. This is consistent with the
level present in primary samples of poorly differentiated
squamous carcinomas where only scattered positive cells are
found while large areas of well-differentiated tumours are
reported positive (Broers et al., 1988). The co-expression of
cytokeratins and vimentin in primary lung squamous car-
cinomas has also been reported (Gatter et al., 1986) and
these cell lines demonstrate both types of intermediate
filament.
The proportion of cells in culture demonstrating evidence
of squamous differentiation as indicated by competence to
form envelopes was low (<1%). Other cell lines derived
from poorly differentiated squamous carcinomas are reported
to have levels between 0 and 60% (Banks-Schlegel et al.,
1985; Levitt et al., 1990; Salge et al., 1990). The percentage of
cells positive for involucrin was similar as was the proportion
of cells positive for cytokeratin 13 and it is very possible that
all three markers are associated with the same cell sub-
population. Comparison with the xenografts indicates that
involucrin-positivity is related to differentiation within these
models.
Cell proliferation was inhibited by TPA with maximum
inhibition at 10-8 M. Above this level TPA appears to block
its own inhibitory effect resulting in increased cell numbers as
compared to those at maximum inhibition. Similar findings
have previously been reported for other modulators of Pro-
tein Kinase C (Dale & Gescher, 1989). After exposure to
10-8 M TPA, the percentage of cells either competent to form
envelopes or to express involucrin was markedly enhanced
and this concentration appears to be about optimal for
induction of involucrin positive cells with higher concentra-
tions resulting in a lower percentage of cells positive for this
marker. Induction of cells competent to form envelopes was
also decreased at concentrations of TPA greater than 10- M.
Salge et al. (1990) have previously shown a similar enhance-
ment of cornified envelope competence by TPA in three lung
squamous cancer cell lines but, in contrast to our data, found
no change in involucrin expression.
In conclusion, we have demonstrated that these cell lines
show a low spontaneous rate of differentiation and that this
level can be enhanced by use of the differentiation inducer
TPA. We believe that these cell lines represent useful model
systems with which to investigate further the mechanisms of
growth and differentiation control in this disease.
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Figure 4 The effect of varying concentrations of TPA on the expression of differentiation markers in the NX002 cell line. The
mean percentage of cells ( ± standard error) positive for involucrin or competent to form cornified envelopes in the cell lines are
shown after exposure to TPA for 4 days. Mean values were obtained from at least five separate measurements. The methods used
to identify involucrin expression and to measure competence to form cornified envelopes are described in Materials and methods.
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